Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-Group Analysis of SMART

Ming Yao, Jun Ni, Lixin Zhou, Bin Peng, Yicheng Zhu, Liying Cui, SMART investigators, Ming Yao, Jun Ni, Lixin Zhou, Bin Peng, Yicheng Zhu, Liying Cui, SMART investigators

Abstract

Background: Although increasing evidence suggests that hyperglycemia following acute stroke adversely affects clinical outcome, whether the association between glycaemia and functional outcome varies between stroke patients with\without pre-diagnosed diabetes remains controversial. We aimed to investigate the relationship between the fasting blood glucose (FBG) and the 6-month functional outcome in a subgroup of SMART cohort and further to assess whether this association varied based on the status of pre-diagnosed diabetes.

Methods: Data of 2862 patients with acute ischemic stroke (629 with pre-diagnosed diabetics) enrolled from SMART cohort were analyzed. Functional outcome at 6-month post-stroke was measured by modified Rankin Scale (mRS) and categorized as favorable (mRS:0-2) or poor (mRS:3-5). Binary logistic regression model, adjusting for age, gender, educational level, history of hypertension and stroke, baseline NIHSS and treatment group, was used in the whole cohort to evaluate the association between admission FBG and functional outcome. Stratified logistic regression analyses were further performed based on the presence/absence of pre-diabetes history.

Results: In the whole cohort, multivariable logistical regression showed that poor functional outcome was associated with elevated FBG (OR1.21 (95%CI 1.07-1.37), p = 0.002), older age (OR1.64 (95% CI1.38-1.94), p<0.001), higher NIHSS (OR2.90 (95%CI 2.52-3.33), p<0.001) and hypertension (OR1.42 (95%CI 1.13-1.98), p = 0.04). Stratified logistical regression analysis showed that the association between FBG and functional outcome remained significant only in patients without pre-diagnosed diabetes (OR1.26 (95%CI 1.03-1.55), p = 0.023), but not in those with premorbid diagnosis of diabetes (p = 0.885).

Conclusion: The present results demonstrate a significant association between elevated FBG after stroke and poor functional outcome in patients without pre-diagnosed diabetes, but not in diabetics. This finding confirms the importance of glycemic control during acute phase of ischemic stroke especially in patients without pre-diagnosed diabetes. Further investigation for developing optimal strategies to control blood glucose level in hyperglycemic setting is therefore of great importance.

Trial registration: ClinicalTrials.gov NCT00664846.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: A report from the american heart association. Circulation. 2014;129:e28–e292 10.1161/01.cir.0000441139.02102.80
    1. Capes SE, Hunt D, Malmberg K, Pathak P, HC G. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2001;32:2426–2432
    1. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet. 1999;353:376–377
    1. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263–270
    1. Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: Pathophysiology and clinical management. Nat Rev Neurol. 2010;6:145–155 10.1038/nrneurol.2009.231
    1. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20–28
    1. Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208–2214
    1. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the ninds rt-pa stroke trial. Neurology. 2002;59:669–674
    1. Roquer J, Rodríguez-Campello A, Cuadrado-Godia E, Giralt-Steinhauer E, Jiménez-Conde J, Dégano IR, et al. Ischemic stroke in prediabetic patients. J Neurol. 2014;261:1866–1870. 10.1007/s00415-014-7431-7
    1. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al.Acute hyperglycemia state is associated with lower tpa-induced recanalization rates in stroke patients. Stroke. 2005;36:1705–1709
    1. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67–71
    1. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of org 10172 in acute stroke treatment (toast) investigators. Neurology. 1999;52:280–284
    1. Bellolio MF, Gilmore RM, Ganti L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2014;1:CD005346 10.1002/14651858.CD005346.pub4
    1. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD, Canadian Alteplase for Stroke Effectiveness Study I. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes care. 2009;32:617–622 10.2337/dc08-1754
    1. Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ecass-ii trial. Stroke. 2008;39:2749–2755 10.1161/STROKEAHA.108.514307
    1. Stead L, Gilmore R, Bellolio M, Mishra S, Bhagra A, Vaidyanathan L, et al. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care. 2009;10:181–186 10.1007/s12028-008-9080-0
    1. Farrokhnia N, Bjork E, Lindback J, Terent A. Blood glucose in acute stroke, different therapeutic targets for diabetic and non-diabetic patients? Acta neurologica Scandinavica. 2005;112:81–87
    1. Ahmed N, Davalos A, Eriksson N, Ford GA, Glahn J, Hennerici M, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: Results from the safe implementation of treatments in stroke international stroke thrombolysis register (sits-istr). Arch Neurol. 2010;67:1123–1130 10.1001/archneurol.2010.210
    1. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303–1306
    1. Peng B, Zhu Y, Cui L, Ni J, Xu W, Zhou L, et al. Standard medical management in secondary prevention of ischemic stroke in china (smart). International journal of stroke: official journal of the International Stroke Society. 2011;6:461–465
    1. Peng B, Ni J, Anderson CS, Zhu Y, Wang Y, Pu C, et al. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in china. Stroke. 2014;45:515–519 10.1161/STROKEAHA.113.001424
    1. Fernandes TG, Goulart AC, Santos-Junior WR, Alencar AP, Bensenor IM, Lotufo PA. Educational levels and the functional dependence of ischemic stroke survivors. Cadernos de saude publica. 2012;28:1581–1590
    1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. The Journal of clinical endocrinology and metabolism. 2002;87:978–982
    1. Roquer J, Giralt-Steinhauer E, Cerda G, Rodriguez-Campello A, Cuadrado-Godia E, Jimenez-Conde J, et al. Glycated hemoglobin value combined with initial glucose levels for evaluating mortality risk in patients with ischemic stroke. Cerebrovascular diseases. 2015;40:244–250 10.1159/000440735
    1. Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: Results from the randomized insulinfarct trial. Stroke. 2012;43:2343–2349 10.1161/STROKEAHA.112.657122
    1. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol. 2010;67:570–578 10.1002/ana.21983
    1. Bruno A, Durkalski VL, Hall CE, Juneja R, Barsan WG, Janis S, et al. The stroke hyperglycemia insulin network effort (shine) trial protocol: A randomized, blinded, efficacy trial of standard vs. Intensive hyperglycemia management in acute stroke. International journal of stroke: official journal of the International Stroke Society. 2014;9:246–251
    1. Toni D, Sacchetti ML, Argentino C, Gentile M, Cavalletti C, Frontoni M, et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol. 1992;239:382–386
    1. Li PA, Shamloo M, Smith ML, Katsura K, Siesjö BK.The influence of plasma glucose concentrations on ischemic brain damage is a threshold function. Neurosci Lett. 1994;177:63–65
    1. Li C, Li PA, He QP, Ouyang YB, Siesjö BK. Effects of streptozotocin-induced hyperglycemia on brain damage following transient ischemia. Neurobiol Dis. 1998;5:117–128
    1. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and pao2 modulation on cortical intracellular acidosis, nadh redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160–170
    1. Ghitescu L, Gugliucci A, Dumas F. Actin and annexins i and ii are among the main endothelial plasmalemma-associated proteins forming early glucose adducts in experimental diabetes. Diabetes. 2001;50:1666–1674

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren